---
title: "Oral tirzepatide vs injections: results | HealthRX.com"
description: "A comparison of oral vs. Injectable tirzepatide covering bioavailability, clinical trial data, weight loss outcomes, dosing, and who each form suits best."
url: https://healthrx.com/glp-1-faq/does-oral-tirzepatide-work-as-well-as-injections-alloy-health
publisher: HealthRX.com
---


HealthRX.com

No oral tirzepatide is FDA approved

[Print or save as PDF](https://healthrx.com/printables/glp-1-faq/does-oral-tirzepatide-work-as-well-as-injections-alloy-health?print=1)

Key numbers

- -20.9% Mean weight change on 15 mg weekly tirzepatide in SURMOUNT-1 adults with obesity or overweight Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35658024/), as cited Nov 7, 2026
- -15.0% Mean weight change on 5 mg weekly tirzepatide in SURMOUNT-1 adults with obesity or overweight Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35658024/), as cited Nov 7, 2026
- -7.4% Mean weight change on 5.5 mg oral orforglipron (Foundayo) in Trial 1 adults with obesity or overweight Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62), as cited Nov 7, 2026
- 25 mg Recommended maintenance dose of oral semaglutide (Wegovy tablets), taken once daily for weight reduction Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b), as cited Nov 7, 2026

[See the public record for Tirzepatide](https://healthrx.com/data/tirzepatide)

HealthRX.com quick answer. There is no FDA-approved oral tirzepatide, so there is no oral version whose results can be compared with the injection. Tirzepatide is sold only as a once-weekly subcutaneous injection: Zepbound for weight reduction and sleep apnea, and Mounjaro for type 2 diabetes [1][2].

At a glance

- FDA-approved oral tirzepatide / None
- Approved tirzepatide products / [Zepbound](https://healthrx.com/zepbound) and Mounjaro, once-weekly subcutaneous injections
- Injectable weight results, SURMOUNT-1 / at 72 weeks, mean weight change was -15.0%, -19.5%, and -20.9% with 5, 10, and 15 mg of tirzepatide, compared with -3.1% with placebo [3]
- FDA-approved oral GLP-1 for weight / Foundayo (orforglipron) tablets [4]
- [Oral semaglutide](https://healthrx.com/rybelsus) for weight / [Wegovy](https://healthrx.com/wegovy) tablets, 25 mg once daily [5]
- Oral versus injectable tirzepatide / No FDA-approved oral tirzepatide exists to compare with the injection [1][2]
- Compounded tirzepatide / not FDA approved and not reviewed by FDA for safety, effectiveness, or quality before marketing [6]

## Is there an oral tirzepatide?

No. Both FDA-approved tirzepatide products are once-weekly subcutaneous injections: Zepbound, for weight reduction and obstructive sleep apnea in adults, and Mounjaro, for type 2 diabetes [1][2]. The Zepbound label lists an absolute bioavailability of 80% for the subcutaneous route and a half-life of about 5 days [1].

An oral tirzepatide tablet or capsule is therefore not an FDA-approved product, and a compounded tirzepatide product, whether oral or injectable, is not FDA approved either. FDA states that compounded drugs are not reviewed for safety, effectiveness or quality before marketing [6].

What people on Reddit report

Replies on a Zepbound forum thread say no oral tirzepatide exists and that the oral GLP-1 tablets on the market are different drugs.

meggieprice · Zepbound

There is no oral tirzepatide. Though Lilly makes Foundayo it is strictly GLP1- similar to oral Wegovy but made differently.

A commenter says the oral product from Lilly is a GLP-1 drug, not tirzepatide, and is made differently from the injection.

[Read the source discussion](https://www.reddit.com/r/Zepbound/comments/1x3fntc/switching_from_zepbound_to_an_oral_glp1/)

chemhobby · Zepbound

There is no oral tirzepatide and you will probably be disappointed by the other oral options.

A commenter says no oral tirzepatide exists and expects the other oral options to disappoint.

[Read the source discussion](https://www.reddit.com/r/Zepbound/comments/1x3fntc/switching_from_zepbound_to_an_oral_glp1/)

Mendelman79_Chicago · Zepbound

There is no such thing as oral tirzepatide.

A commenter states that oral tirzepatide does not exist.

[Read the source discussion](https://www.reddit.com/r/Zepbound/comments/1x3fntc/switching_from_zepbound_to_an_oral_glp1/)

Questions worth asking

Choose the questions you want to keep Is there an FDA-approved oral form of tirzepatide? Are Zepbound and Mounjaro both injections only? Which oral GLP-1 tablets are approved for weight management? How do oral semaglutide and orforglipron differ from tirzepatide? Is compounded tirzepatide safe when it is not FDA approved? What dose would I start on if I switched from an injection to a tablet?

## Compounded tirzepatide: where it stands

FDA declared the [tirzepatide](https://healthrx.com/products/tirzepatide) injection shortage resolved on 2024-12-19, and compounding that depended on the shortage ended in 2025 [7]. As of 2026-05-31, FDA had received more than 730 adverse event reports for compounded tirzepatide, a figure the agency says likely undercounts [6]. On 2026-04-30 FDA proposed to exclude tirzepatide from the list of bulk substances outsourcing facilities may compound with, finding no clinical need. Comments were due 2026-06-29, and FDA said no final decision had been made [8].

## The results an oral version would have to match

The injected form's benchmark is SURMOUNT-1: 2,539 adults with obesity or overweight and no diabetes, 72 weeks of weekly tirzepatide versus placebo. Mean weight change was -15.0% at 5 mg, -19.5% at 10 mg and -20.9% at 15 mg, against -3.1% on placebo [3]. Maintenance doses are 5, 10 or 15 mg weekly; 2.5 mg is a starting dose only and is not approved as a maintenance dose [1].

## The approved oral GLP-1 drugs are different molecules

Two once-daily tablets are FDA approved for weight management, and neither contains tirzepatide.

Foundayo (orforglipron) was approved on April 1, 2026 [9] and can be taken with or without food. In its label's Trial 1 (3,127 adults with obesity or overweight, no diabetes, 72 weeks), mean weight change was -7.4% at 5.5 mg, -8.3% at 9 mg and -11.1% at 17.2 mg, against -2.1% on placebo [4].

Wegovy tablets contain semaglutide, with a recommended maintenance dose of 25 mg once daily for weight reduction. The label says to take them on an empty stomach in the morning with up to 4 ounces of water and to wait at least 30 minutes before eating, drinking other beverages or taking other oral medicines [5].

Neither result is a head-to-head comparison with injectable tirzepatide. The Zepbound label states that coadministration with any GLP-1 receptor agonist is not recommended [1].

Dr Haque on why oral GLP-1 pills demand a strict routine

Dr. Haque argues that a pill is not simply the easier choice. In his view, oral GLP-1 medicines depend on a strict routine, since the body absorbs only a small fraction of the dose, and missing the fasting, water, and waiting rules can leave almost nothing working. He notes that oral semaglutide gives weight loss close to the injection, but with more stomach side effects and a higher rate of stopping early. He also says the oral form has less cardiovascular data, so people focused on heart risk may want to wait for more research. He suggests talking with a doctor about lifestyle, comfort with needles, refrigeration access, and travel before choosing, and he states that tirzepatide is more effective than semaglutide overall.

Who is speaking?

Dr. Haque. Physician with MD and PhD credentials, as named on the channel Dr. Haque, MD, PhD - Medical Wisdom [Background](https://www.youtube.com/watch?v=4hwZg7ANBYA)

[Episode notes and full video](https://www.youtube.com/watch?v=4hwZg7ANBYA)

## What the injection's label lists

In the pooled Zepbound weight trials, nausea occurred in 25% (5 mg), 29% (10 mg) and 28% (15 mg) versus 8% on placebo; diarrhea in 19%, 21% and 23% versus 8%; vomiting in 8%, 11% and 13% versus 2% [1]. Labeled warnings include severe gastrointestinal reactions (it is not recommended in severe gastroparesis), acute kidney injury from volume depletion, acute gallbladder disease, acute pancreatitis, hypoglycemia when combined with insulin or a sulfonylurea, serious hypersensitivity, and pulmonary aspiration during general anesthesia or deep sedation [1].

The label advises people using oral hormonal contraceptives to switch to a non-oral method or add a barrier method for 4 weeks after starting and for 4 weeks after each dose increase [1].

Check what you know

Think you have it? Try 3 quick questions and see what the article says.

1. According to the article, is an oral tirzepatide tablet FDA approved?

Question 1 of 3

Score: 0 right, 0 of 3 answered

Try the tool

Tirzepatide dose calculator and dosage chart

Convert a tirzepatide dose between mg, mL and U-100 syringe units, with the 2.5 to 15 mg label chart.

[Open the dose calculator](https://healthrx.com/tools/tirzepatide-dose-calculator)

Printable question sheet

Oral versus injected tirzepatide questions for your prescriber

Use this sheet before a visit or pharmacy call if you are asking about tirzepatide in pill form, compounded tirzepatide, or switching to an oral weight medicine. Fill it in by hand and bring it with your current labels.

[Open the fill-in sheet](https://healthrx.com/printables/glp-1-faq/does-oral-tirzepatide-work-as-well-as-injections-alloy-health) Fill it in, print it or save it as a PDF. No sign-up.

Frequently asked questions

Is oral tirzepatide FDA-approved?

No. Zepbound and Mounjaro are both once-weekly subcutaneous injections, and a compounded tirzepatide product is not FDA approved [1][2][6].

Does tirzepatide come in a pill?

Not as an FDA-approved product. The approved tirzepatide products, Zepbound and Mounjaro, are once-weekly subcutaneous injections [1][2].

Is there an oral GLP-1 tablet for weight loss?

Yes, but they are different drugs from tirzepatide. Foundayo (orforglipron) and Wegovy tablets (semaglutide) are the FDA-approved once-daily tablets for weight management, and the Zepbound label says coadministration with another GLP-1 receptor agonist is not recommended [4][5][1].

How much weight loss does injectable tirzepatide produce?

In SURMOUNT-1, 72 weeks of weekly tirzepatide produced mean weight changes of -15.0%, -19.5% and -20.9% at 5, 10 and 15 mg versus -3.1% on placebo [3].

Is compounded tirzepatide FDA approved?

No. FDA states that compounded drugs are not FDA approved and are not reviewed for safety, effectiveness or quality before marketing [6].

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

Are tirzepatide injections or pills more effective?

No comparison is possible because no FDA-approved oral tirzepatide exists. Both approved tirzepatide products, Zepbound and Mounjaro, are once-weekly injections. In SURMOUNT-1, the injection produced mean weight changes of -15.0%, -19.5% and -20.9% at 5, 10 and 15 mg over 72 weeks, against -3.1% on placebo.

Do oral GLP-1 work as well as injections?

Not established. The approved oral GLP-1 tablets, Foundayo (orforglipron) and Wegovy tablets (semaglutide), are different molecules, and neither result is a head-to-head comparison with injectable tirzepatide. In Foundayo's label Trial 1, mean weight change was -7.4% to -11.1% at the tested doses, against -2.1% on placebo.

References

Show all 11 references Hide references

1. U.S. National Library of Medicine, DailyMed. Zepbound injection (tirzepatide) prescribing information. [Zepbound injection (tirzepatide) label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
2. U.S. National Library of Medicine, DailyMed. Mounjaro injection (tirzepatide) prescribing information. [Mounjaro injection (tirzepatide) label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0)
3. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. [Tirzepatide Once Weekly for the Treatment of Obesity](https://pubmed.ncbi.nlm.nih.gov/35658024/). N Engl J Med. 2022;387(3):205-216.
4. U.S. National Library of Medicine, DailyMed. Foundayo (orforglipron) tablets prescribing information. [Foundayo (orforglipron) tablets label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62)
5. U.S. National Library of Medicine, DailyMed. Wegovy injection and tablets prescribing information. [Wegovy injection and tablets label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
6. [FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA](http://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss).
7. [FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize | FDA](https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize).
8. [FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on Bulks List | FDA](https://www.fda.gov/news-events/press-announcements/fda-proposes-exclude-semaglutide-tirzepatide-and-liraglutide-503b-bulks-list).
9. [Drugs@FDA: FDA-Approved Drugs](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220934).
10. Reddit participants. [Switching from Zepbound to an oral GLP-1? (r/Zepbound)](https://www.reddit.com/r/Zepbound/comments/1x3fntc/switching_from_zepbound_to_an_oral_glp1/). Accessed 2026-11-10.
11. Dr. Haque, MD, PhD - Medical Wisdom. [GLP-1 Pills vs. Injections: I Compared the Evidence](https://www.youtube.com/watch?v=4hwZg7ANBYA). Accessed 2026-11-10.

Next in this cluster

Related reading

- [tirzepatide STEP-1 vs SURMOUNT-1](https://healthrx.com/glp-1/compare-step1-surmount1)
- [tirzepatide Tirzepatide weight loss](https://healthrx.com/off-label-mounjaro/weight-loss--evidence-summary)
- [tirzepatide Zepbound switching](https://healthrx.com/reviews-zepbound/switching-reports)
- [tirzepatide Tirzepatide: Dosing, Weight Loss Results & FDA Approval](https://healthrx.com/glp-1/tirzepatide)
- [tirzepatide GLP-1 medications vs older obesity drugs](https://healthrx.com/glp-1-faq/how-are-these-new-glp-1-medications-different-from-older-treatments-for-obesity-)
- [tirzepatide Medication shortage](https://healthrx.com/glp-1-faq/how-can-i-stay-up-to-date-on-medication-shortages-calibrate)
- [general health FDA-approved medication](https://healthrx.com/glp-1-faq/how-can-i-tell-if-a-pharmacy-or-medication-is-fda-approved-calibrate)
- [zepbound tirzepatide Zepbound safety](https://healthrx.com/glp-1-faq/how-does-calibrate-ensure-zepbound-is-prescribed-safely-calibrate)
- [tirzepatide Mounjaro vs GLP-1](https://healthrx.com/glp-1-faq/how-does-mounjaro-differ-from-other-glp-1-medications-calibrate)
- [tirzepatide How does Mounjaro work](https://healthrx.com/glp-1-faq/how-does-mounjaro-work-calibrate)
- [liraglutide How Does Saxenda® Work? A Clinical Deep-Dive](https://healthrx.com/glp-1-faq/how-does-saxenda-work-calibrate)
- [tirzepatide GLP-1 impulse control](https://healthrx.com/glp-1-faq/how-glp-1-s-like-semaglutide-help-with-impulse-control)
- [saxenda vs trulicity Saxenda vs Trulicity](https://healthrx.com/compare-glp-1/saxenda-vs-dulaglutide-trulicity--side-effects)
- [glp 1 receptor agonist dosing GLP-1 dose response](https://healthrx.com/glp-1/dose-response)

![oral tirzepatide: researcher's gloved hands handling plain tablets on a laboratory bench](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/glp-1-faq/does-oral-tirzepatide-work-as-well-as-injections-alloy-health.webp)

Whether a tablet could match an injection is a bioavailability question that laboratory and clinical research must answer. Full oral tirzepatide guide and sources at [healthrx.com/glp-1-faq](https://healthrx.com/glp-1-faq).

> Compounded drugs are not FDA-approved or reviewed by FDA for safety, effectiveness, or quality before marketing.
